Clinical Trials List
2021-05-18 - 2023-12-31
Phase II
Recruiting5
Terminated5
-
-
Trial Applicant
PAREXEL INTERNATIONAL CO., LTD.
-
Sponsor
-
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/09/23
Investigators and Locations
Co-Principal Investigator
- Wen-Chung Yu 無
- 吳承學 無
- Shih-Hsien Sung 無
- 張俊欽 無
- 黃少嵩 無
- 黃偉銘 無
- Hao-min Cheng 無
- Tse-Min Lu 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Chih-Jen Wu 無
- 吳培甄 無
- 宋國慈 無
- 蔡瑞鵬 無
- 顏志軒 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Chun-Yuan Chu 無
- 吳韋璁 無
- Hsiang Chun Lee 無
- Po-Chao Hsu 無
- 蔡子賢 無
- Wei-Chung Tsai 無
- Ye-Hsu Lu 無
- 顏學偉 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- 吳軍毅 無
- CHENG-HSU CHEN 無
- 蔡尚峰 無
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- Te-Chao Fang 無
- Chih-Chin Kao 無
- 陳靜怡 無
- Shu-Ching Yeh 無
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- Wen-Chin Lee 無
- 李隆志 無
- 邱千華 無
- 許淳惟 無
- CHIH-CHAO YANG 無
- 劉文浩 無
- 劉志翰 無
- 鍾昇穎 無
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Terminated
Study Contacts
- -
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
Exclusion Criteria
The Estimated Number of Participants
-
Taiwan
30 participants
-
Global
540 participants
